Sympathetic hyperactivity in Wistar rats with insulin-resistance

Area of Science:

• Endocrinology
• Cardiovascular Physiology
• Metabolic Syndrome

Background:

• Insulin resistance is a metabolic condition associated with increased cardiovascular risk.
• Sympathetic nervous system (SNS) overactivity is implicated in hypertension and metabolic disorders.
• The precise role of hyperinsulinemia in modulating SNS activity in insulin resistance requires further elucidation.

Purpose of the Study:

• To investigate the effect of sustained hyperinsulinemia on sympathetic function in insulin-resistant rats.
• To determine the relationship between insulin resistance, plasma norepinephrine levels, and glucose homeostasis.
• To explore potential therapeutic targets for modulating sympathetic hyperactivity in insulin resistance.

Main Methods:

• Wistar rats with induced insulin resistance were studied.
• Plasma glucose and norepinephrine (NE) levels were measured under basal conditions and after glucose challenge.
• Pharmacological agents (guanethidine and prazosin) were used to assess their impact on sympathetic activity.

Main Results:

• Insulin-resistant rats exhibited significantly higher basal plasma glucose and NE levels compared to normal and diabetic rats.
• Treatment with guanethidine and prazosin normalized the elevated sympathetic responses in insulin-resistant rats.
• Elevated plasma insulin levels during glucose challenge confirmed endogenous insulin's role in sympathetic hyperactivity.

Conclusions:

• Sustained hyperinsulinemia in insulin resistance is associated with increased sympathetic nervous system activity.
• This heightened sympathetic activity may contribute to the hypertension risk observed in diabetic patients.
• Targeting sympathetic overactivity could be a therapeutic strategy for managing complications associated with insulin resistance and diabetes.